Postnatal administration of phencyclidine (PCP) in rodents causes major disturbances to neurological processes resulting in severe modifications to normal behavioral traits into adulthood. It is routinely used to model psychiatric disorders such as schizophrenia, producing many of the dysfunctional processes in the brain that are present in this devastating disorder, including elevated levels of apoptosis during neurodevelopment and disruptions to myelin and plasticity processes. Lingo-1 (or Leucine-rich repeat and immunoglobulin domain-containing protein) is responsible for negatively regulating neurite outgrowth and the myelination of axons. Recent findings using a postmortem human brain cohort showed that Lingo-1 signaling partners in the Nogo receptor (NgR)/p75/TNF receptor orphan Y (TROY) signaling complex, and downstream signaling partners With No Lysine (K) (WNK1) and Myelin transcription factor 1 (Myt1), play a significant part in schizophrenia pathophysiology. Here we have examined the implication of Lingo-1 and its signaling partners in a neurodevelopmental model of schizophrenia using PCP to determine if these pathways are altered in the hippocampus throughout different stages of neurodevelopment. Male Sprague-Dawley rats were injected subcutaneously with PCP (10 mg/kg) or saline solution on postnatal days (PN) 7, 9, and 11. Rats (n = 6/group) were sacrificed at PN12, 5 weeks, or 14 weeks. Relative expression levels of Lingo-1 signaling proteins were examined in the hippocampus of the treated rats. p75 and Myt1 were decreased (0.001 ≤ p ≤ 0.011) in the PCP treated rats at PN12. There were no significant changes in any of the tested proteins at 5 weeks (p N 0.05). At 14 weeks, p75, TROY, and Myt1 were increased in the PCP treated rats (0.014 ≤ p ≤ 0.022). This is the first report of an alteration in Lingo-1 signaling proteins in the rat hippocampus, both directly after PCP treatment in early development and in adulthood. Based on our results, we propose that components of the Lingo-1 signaling pathways may be involved in the acute neurotoxicity induced by perinatal administration of PCP in rats early in development and suggest that this may have implications for the hippocampal deficits seen in schizophrenia.
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Introduction
Phencyclidine, also known as angel dust or PCP, is both a potent non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist and an agonist for the dopamine D2 receptors (Kapur and Seeman, 2002; Seeman, 2009; Seeman et al., 2005) , but also binds with a lower affinity to opiate, nicotinic, and muscarinic cholinergic receptors (Amir et al., 1985; Hustveit et al., 1995; Maayani and Weinstein, 1980; Zukin, 1982) . Due to its effects on a multitude of important receptor targets known to be implicated in the schizophrenia pathology, PCP treatment in rodents has been used to model the glutamate hypofunction hypotheses and dopamine hyperfunction hypotheses of schizophrenia (Seeman, 2009; Moghaddam and Krystal, 2012) . The use of PCP administration at postnatal days (PN) 7, 9, and 11 has consistently been shown to induce hyperlocomotion, reduced prepulse inhibition, and impaired social interactions in rodents (Du Bois et al., 2008; Harich et al., 2007;  Progress in Neuro-Psychopharmacology & Biological Psychiatry 63 (2015) [91] [92] [93] [94] [95] [96] [97] Abbreviations: Akt, protein kinase B; BAX, Bcl-2-associated X protein; BDNF, brainderived neurotrophic factor; ERK1/2, extracellular signal-regulated kinase 1/2; Lingo-1, Leucine-rich repeat and immunoglobulin domain-containing protein; MAP2, microtubule-associated protein 2; MBP, myelin basic protein; MDM2, Mouse double minute 2 homolog; MEK1/2, mitogen/extracellular signal-regulated kinase 1/2; Myt1, Myelin transcription factor 1; Myt1l, Myelin transcription factor 1-like; NgR, Nogo receptor; NMDA, N-methyl-D-aspartate; PCP, phencyclidine; PI3-K, phosphoinositide 3-kinase; PN, postnatal day; Trk, tropomyosin receptor kinase; TROY, TNF receptor orphan Y; WNK1, With No Lysine (K).
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